Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PM
PM logo

PM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Philip Morris International Inc (PM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
178.400
1 Day change
-0.58%
52 Week Range
193.050
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Philip Morris International Inc (PM) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has positive long-term growth prospects driven by smoke-free product expansion, strong analyst ratings, and recent congressional purchases indicating confidence in the stock. Despite short-term technical weakness, the company's fundamentals and strategic initiatives support a long-term investment case.

Technical Analysis

The technical indicators are mixed. The MACD histogram is negative and expanding downward, suggesting bearish momentum. The RSI is neutral at 42.763, and the stock is trading below its pivot level of 179.692, indicating potential short-term weakness. However, the moving averages (SMA_5 > SMA_20 > SMA_200) are bullish, signaling a positive long-term trend.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
7

Positive Catalysts

  • Analysts have raised price targets recently, with Morgan Stanley and BofA highlighting confidence in smoke-free growth and durable earnings.

  • Congress members have made significant purchases of the stock, indicating confidence in its long-term potential.

  • Leadership changes in key regions aim to enhance the company's strategic focus on a smoke-free future.

Neutral/Negative Catalysts

  • Short-term technical indicators suggest bearish momentum.

  • UBS and Morgan Stanley have lowered price targets recently due to forex impacts and lower Zyn shipments.

  • The stock has a mixed short-term trend with a 50% chance of a slight decline in the next week and month.

Financial Performance

Financial data for the latest quarter is unavailable, but analysts remain confident in the company's durable earnings outlook and smoke-free growth strategy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain a positive outlook, with recent price target increases from Morgan Stanley ($200) and BofA ($209). Analysts cite strong operations, visibility into smoke-free growth, and durable earnings as key drivers.

Wall Street analysts forecast PM stock price to rise
11 Analyst Rating
Wall Street analysts forecast PM stock price to rise
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 179.440
sliders
Low
175
Averages
191.95
High
210
Current: 179.440
sliders
Low
175
Averages
191.95
High
210
Morgan Stanley
Overweight
maintain
$190 -> $200
AI Analysis
2026-06-03
Reason
Morgan Stanley
Price Target
$190 -> $200
AI Analysis
2026-06-03
maintain
Overweight
Reason
Morgan Stanley raised the firm's price target on Philip Morris to $200 from $190 and keeps an Overweight rating on the shares. Philip Morris' announcement at an investor conference that it will be launching Zyn Ultra in the U.S. this month and the IQOS Japan update increase the firm's confidence, says the analyst, who is also trimming the firm's Q2 and FY26 estimates by 5c for forex, consistent with the company's updated outlook.
BofA
Lisa Lewandowski
Buy
maintain
$200 -> $209
2026-05-20
Reason
BofA
Lisa Lewandowski
Price Target
$200 -> $209
2026-05-20
maintain
Buy
Reason
BofA analyst Lisa Lewandowski raised the firm's price target on Philip Morris to $209 from $200 and keeps a Buy rating on the shares. The firm views the recent changes in the FDA's enforcement approach for vapes and nicotine pouches as "a positive development," says the analyst, who believes a premium is justified given the strength of Philip Morris' operations, visibility into smoke-free growth, and durable earnings outlook. While also noting that the company announced the appointment of Massimo Andolina as Group CFO, the firm says it expects "a smooth and orderly transition from Babeau to Andolina, with continuity in both strategy and capital allocation."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PM
Unlock Now

People Also Watch